IL-8 signaling triggers angiogenic responses in ECs, promotes proliferation and survival of endothelial and tumor cells, and increases the migration of tumor cells, ECs, and infiltrating neutrophils at the tumor site. This evidence concerns the gene CXCL8 and neoplasm.